Hara Episkopou, PhD

VP R&D

Hara brings nearly 20 years of experience in oncology and cell biology, with a focus on cancer biomarkers and therapeutic target discovery. She earned her PhD from the Medical School, University of Athens and completed postdoctoral research at de Duve Institute of UCLouvain, Brussels, specializing in telomere biology and cancer therapeutics. She subsequently transitioned to biotech, taking on leadership roles in cell therapy development, including preclinical program design, assay development and regulatory support. Since joining Novadip Biosciences in 2020, Hara has led preclinical research and discovery programs, guiding the development of innovative regenerative and cell-based therapies.